<DOC>
	<DOCNO>NCT00663182</DOCNO>
	<brief_summary>The aim study evaluate effect Entecavir patient With decompensated HBV-Related cirrhosis .</brief_summary>
	<brief_title>Entecavir Patients With Decompensated Hepatitis B Virus ( HBV ) -Related Cirrhosis</brief_title>
	<detailed_description>Chronic hepatitis B one widespread viral infection worldwide , potentially lead liver cirrhosis hepatocellular carcinoma . Previous study demonstrate patient active viral replication , define presence detectable serum HBV-DNA HBeAg , increase risk develop progressive liver disease death.The prognosis decompensated cirrhosis result chronic hepatitis B virus infection poor . Anti-viral therapy decompensated HBV-related cirrhosis recommend American Association Study Liver Diseases . However , high quality research effectiveness anti-viral therapy decompensated cirrhosis perform . Entecavir new nucleotide analogue , prove effective suppress viral replication decrease necroinflammatory response , recommend first-line medication AASLD guideline . Our purpose evaluate effect Entecavir patient With decompensated HBV-Related cirrhosis . The main outcome liver function , HBV-DNA , disease progression , hepatocellular carcinoma , Child-Pugh score survival .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>1. 16 year age ; 2. evidence active viral replication document positive test HBVDNA serum ; 3 . Liver cirrhosis proven ultrasound CT ; 4 . Decompensated cirrhosis evidence ChildPugh score â‰¥ 7 ; 5. patient decompensation sign jaundice , ascites , variceal bleeding , hepatic encephalopathy 1. evidence hepatocellular carcinoma ( suspicious focus hepatic ultrasonography screen rise serum level alphafetoprotein ) 2. serum alanine aminotransferase level 10 time upper limit normal 3. coinfection hepatitis C D virus human immunodeficiency virus 4. type cirrhosis 5. history antiviral therapy 6. total bilirubin level high 170 mmol/L 7. history malignant tumor</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Entecavir</keyword>
	<keyword>cirrhosis</keyword>
	<keyword>anti-viral</keyword>
	<keyword>therapy</keyword>
</DOC>